Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US
Samuel Aballéa, Jeremy V.M. Chancellor, Maria Raikou, Michael F. Drummond, Milton C. Weinstein, Sophia Jourdan, John BridgewaterVolume:
109
Année:
2007
Langue:
english
Pages:
8
DOI:
10.1002/cncr.22512
Fichier:
PDF, 148 KB
english, 2007